Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats. (Q34421594)
scientific article
Language:
(P31) (Q13442814)
(P304) 208-217
(P407) (Q1860)
(P433) 1
(P478) 281
(P577) Tuesday, April 1, 1997
(P921) (Q325101)
(Q60315441)
(P1433) (Q1500272)
(P1476) "Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats" (language: en)
(P2093) Honore P
Buritova J
Fournié-Zaluski MC
Roques BP
Besson JM
other details
description scientific article

External Links